Marco Matteo Ciccone

Prof. Dr. Marco Matteo Ciccone


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MGMargherita Ilaria Gioia
Margherita Ilaria Gioia
GPGiuseppe Parisi
Giuseppe Parisi
DGDario Grande
Dario Grande
MAMiriam Albanese
Miriam Albanese
GAGianmarco Alcidi
Gianmarco Alcidi
MIMassimo Iacoviello
Massimo Iacoviello
Background: Sacubitril/valsartan plays a key role in improving left ventricular remodeling and prognosis in patients with heart failure with a reduced ejection fraction (HFrEF). Moreover, some data support its role in preserving renal function. In order to better clarify the effects of sacubitril/valsartan in cardiorenal syndrome, this study evaluated its effects on the renal resistance index (RRI). Methods: A group of patients with HFrEF was enrolled. The RRI was assessed with renal echo-color Doppler at enrollment and again after at least six months of sacubitril/valsartan treatment. In a subgroup of patients, the RRI was also evaluated at least six months before enrollment. The variations in echocardiographic parameters reflecting the left and right ventricular function, as well as creatinine and the estimated glomerular filtration rate, were also evaluated. Results: After treatment with sacubitril/valsartan, significant improvements in the left ventricular ejection fraction, and a decrease in the left atrial and ventricular volumes were observed. The RRI also showed a significant decrease. No relationship was found between the improvements in the parameters reflecting cardiac function and changes in the RRI. Conclusions: Treatment with sacubitril/valsartan is associated with improvements in both left ventricular function and renal perfusion, through decreasing the renal resistance. These data help to clarify the effects of the drug on cardiorenal syndrome progression.

1 November 2020 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
Roberta ZupoRoberta Zupo
Roberta Zupo
Fabio Stefano CastellanaFabio Stefano Castellana
Fabio Stefano Castellana
RSRodolfo Sardone
Rodolfo Sardone
Pietro ScicchitanoPietro Scicchitano
Pietro Scicchitano
LLLuisa Lampignano
Luisa Lampignano
GPGiovanni De pergola
Giovanni De pergola

25 April 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
MPMartino Pepe
Martino Pepe
GNGianluigi Napoli
Gianluigi Napoli
Maria Cristina CarellaMaria Cristina Carella
Maria Cristina Carella
DFDaniele De Feo
Daniele De Feo
RTRocco Tritto
Rocco Tritto
MCMarco Matteo Ciccone
Marco Matteo Ciccone
Isotretinoin or 13-cis-retinoic acid (RA) is one of the most effective and widely used drugs for the treatment of severe acne vulgaris. Despite being deemed safe, no definite consensus has been reached on the cardiovascular risk of RA derivatives. We report a case of heart failure due to dilated cardiomyopathy (DCM) and concomitant renal infarction occurring after 5 months of isotretinoin use in a previously healthy 18-year-old male. The patient, with a history of acne vulgaris, presented to our emergency department with left iliac fossa pain and effort dyspnea. A trans-thoracic echocardiogram showed DCM and severely reduced left ventricle ejection fraction (LVEF: 29%). During hospitalization, a total body computed tomography (CT) showed an ischemic lesion in the left kidney. Ischemic, autoimmune, infective, and heritable causes of DCM were ruled out. Cardiac magnetic resonance (CMR) evidenced LV circumferential mid-wall late gadolinium enhancement. Heart failure therapy was promptly started and up-titrated, but only poor LVEF improvement was detected overtime. Our case aims to raise awareness on rare life-threatening cardiovascular events possibly associated with isotretinoin use. To the best of our knowledge, this is the first described case of renal thromboembolism and severe DCM leading to implantable cardioverter-defibrillator (ICD) implantation occurring during isotretinoin treatment.